A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport - Wikidata - wikimedia - TriplyDB

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

http://www.wikidata.org/entity/Q24603087

about

Angiopoietin-like 4 regulates epidermal differentiation.The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.PPARdelta regulates glucose metabolism and insulin sensitivity PPAR delta: a dagger in the heart of the metabolic syndrome.Critical roles of PPAR beta/delta in keratinocyte response to inflammation The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention PPARs and the cardiovascular system Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms Nuclear receptors and AMPK: can exercise mimetics cure diabetes?Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases Road to exercise mimetics: targeting nuclear receptors in skeletal muscle Nuclear receptors in bone physiology and diseases Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Peroxisome proliferator-activated receptors in cutaneous biology Fibrates, glitazones, and peroxisome proliferator-activated receptors Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta PPARδ regulates satellite cell proliferation and skeletal muscle regeneration PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome An ethanol extract of Artemisia iwayomogi activates PPARδ leading to activation of fatty acid oxidation in skeletal muscle PPARs and the complex journey to obesity PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Nuclear receptors as drug targets for metabolic disease.PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.A novel model of cholesterol efflux from lipid-loaded cells HVC1 ameliorates hyperlipidemia and inflammation in LDLR-/- mice.Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse.Role of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation.Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.

P2860

Q21135146-06EA1BA9-5126-43C0-88CD-33259FBDDD80 Q24530668-87BDD3D5-827B-4413-84EF-CAB4515B885D Q24541495-7BF36B3E-3F9E-4668-BACF-53B26CB604DE Q24541527-9AB7CE75-B591-4636-B1DF-18F44767386C Q24599297-0264E5D6-E20E-48C0-A361-F702FEA167EF Q24601222-7228F035-1EF0-4706-8097-9E700CD3F4CF Q24642728-2B53EE36-E275-4109-83E5-CDA1D7A2338B Q24815580-35B07914-6499-46CD-97E8-62F1DA0B9AF7 Q26750875-8BC78987-141D-492D-8147-8796B2958157 Q26772316-CB2BA43A-42CC-4B19-B2E1-482770577FF9 Q26825467-10FF3B64-899E-4A8B-8397-ACC2A6D87AEA Q26825855-1A90364C-983C-45BB-BAA8-C8CA2715F00D Q26853017-446A0CE9-DC22-4ADD-8C2F-1FBBF1A38FE3 Q27636062-51019A2A-C118-4AFB-8CAF-2C46DB95FF28 Q27666968-B4E9A818-EF10-4B00-98A5-B3D1BCAF036A Q27687166-73EA8835-6009-4952-AB0B-00124A8D6608 Q28202926-CE29189E-4398-4DE8-93F1-3BDDF5998609 Q28279732-89EA79DF-9521-4C80-9979-BDD293E18A49 Q28299905-1805FAC1-602A-452F-ACC2-2C6AF9A4CC42 Q28483670-0BC1E72C-7FBB-4E15-B933-431F4BB1805D Q28504818-810D15A1-9FE5-431C-B749-2CBAC1146E72 Q28512796-C8829E38-A7D3-4B69-96D1-060A22E3C713 Q28568373-AFA92B1A-2DBA-4DF8-BBA8-F44394824CC5 Q28569006-3A9B7707-0EC4-45E3-9A7D-A27744E386C4 Q28572349-32305BEC-BC91-40F6-92B6-DF20A9E2E843 Q28589921-6F7E5CCD-2122-42EA-B7E8-4CB4A52A8950 Q28592809-07CF5D20-3E21-487C-A2A6-CDA9814E851E Q28730913-ECE7E089-BAD7-4CA1-9F87-B4961543397C Q29619271-5D7EA4D4-0611-4790-928E-818E8BC97745 Q30241952-4BDA5A25-F18D-4A73-AC60-33239A094B22 Q30353176-A84C3036-2A39-433B-A39A-45D70FB58705 Q30430126-2E61343F-3639-4AC9-BEC6-776B45FA37C7 Q30482025-8C1F56BA-A3EB-4839-BEDF-3C141B40DE02 Q30486738-B57A0087-E222-462A-996A-3A36744A0B8B Q33294481-DFC5AAAA-FFBA-4E89-A2FA-C692C5050FB2 Q33577644-24269F8E-5385-4364-9EB2-DBA851E935AB Q33582240-BE2B0ACE-48EB-44E1-8059-6F34ABC43C56 Q33600094-FD9C0EED-492B-44DE-A3EE-7F2B53DE9CB7 Q33614818-274929FE-5FD3-4130-BC9D-E086F6ECF60F Q33625872-AE6AC305-CB7B-42C3-8841-51FDBCEC4CBF

P2860

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

http://www.wikidata.org/entity/Q24603087

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

A selective peroxisome prolife ...... reverse cholesterol transport

@ast

A selective peroxisome prolife ...... reverse cholesterol transport

@en

A selective peroxisome prolife ...... reverse cholesterol transport

@nl

type

label

A selective peroxisome prolife ...... reverse cholesterol transport

@ast

A selective peroxisome prolife ...... reverse cholesterol transport

@en

A selective peroxisome prolife ...... reverse cholesterol transport

@nl

prefLabel

A selective peroxisome prolife ...... reverse cholesterol transport

@ast

A selective peroxisome prolife ...... reverse cholesterol transport

@en

A selective peroxisome prolife ...... reverse cholesterol transport

@nl

P1433

Q24603087-96539EB7-2739-454B-A319-3FAAEFB2BAA5

P1476

Q24603087-0DA4F60D-FC24-4A89-BF95-2A90C62D68C2

P2093

Q24603087-0B139970-0E9D-435B-A4C4-23F87CB7C3EF

Q24603087-421A43B4-2A0F-448D-92F0-C629710425E0

Q24603087-6AAE6331-CA11-4198-9B52-D7E7649EE545

Q24603087-6BDC851A-8131-41B1-918F-49054651D7F9

Q24603087-704AC805-3CB7-4599-AF08-FD6901883150

Q24603087-73D56F37-C37C-480C-B587-5021821D6A51

Q24603087-92803BDF-6A74-470D-A656-48D2064023EB

Q24603087-95C1CB68-6FFA-4A29-9717-91501BD14C48

Q24603087-A55F1A7E-962E-4EB9-939A-295D32EB4928

Q24603087-A9D96E6F-C095-41C2-9932-A4A58A8EBF8E

P2860

Q24603087-02E4A9B0-E347-40D4-9934-210E1E806E7F

Q24603087-049EA9DE-6A3E-4BC6-AFD5-EAD69B94DF1F

Q24603087-04F2BCC6-1295-4338-87F9-51684856036E

Q24603087-07F2684A-4875-48EF-8FB2-0C84D57E621E

Q24603087-136D5F65-588C-45CC-9646-7B6F594637A6

Q24603087-2CBADDCB-EA67-4CA1-B3FB-80CB6356FB49

Q24603087-35C7AE74-C1C3-4F37-A11B-4158237E9132

Q24603087-42552DF6-8D97-43D3-85B6-6CCE23E7CF50

Q24603087-42799CE0-84D5-48AF-8A12-8EB376FE39B9

Q24603087-42B9DE4B-04C2-4A9F-B61B-D5BD9AB98EF2

P304

Q24603087-86CB3590-A68B-49AF-936B-EB8F6C4E6875

P31

Q24603087-11E0BAB0-94F7-4262-A6A0-3145E34D0BA9

P356

Q24603087-2667D225-1AC2-41B5-8559-590FF975F8B6

P407

Q24603087-2E55913A-0D7D-44A4-ABBD-84EAE905DFD0

P433

Q24603087-608F20EE-7B81-439E-8F7B-9ACEEE9D01BE

P478

Q24603087-EFA994F0-D9E6-4E1B-8363-A23EEDB10402

P577

Q24603087-9CF6EB47-5E6A-45DF-86D9-7E8DE56A19C7

P5875

Q24603087-55B565D0-9858-4ADA-8A5A-7BE934422781

P698

Q24603087-D43EB146-C034-4924-8D58-27F3F4D1F3A8

P932

Q24603087-E5881989-039F-4861-9450-0B1805545A07

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A selective peroxisome prolife ...... reverse cholesterol transport

@en

P2093

B C Hansen

http://www.w3.org/2001/XMLSchema#string

C S Russell

http://www.w3.org/2001/XMLSchema#string

D A Winegar

http://www.w3.org/2001/XMLSchema#string

D D Sternbach

http://www.w3.org/2001/XMLSchema#string

H E Xu

http://www.w3.org/2001/XMLSchema#string

J L Shenk

http://www.w3.org/2001/XMLSchema#string

K D Plunket

http://www.w3.org/2001/XMLSchema#string

M C Lewis

http://www.w3.org/2001/XMLSchema#string

M H Lambert

http://www.w3.org/2001/XMLSchema#string

M L Sznaidman

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Mechanism of action of fibrates on lipid and lipoprotein metabolism

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

P304

5306-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.091021198

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12024129

http://www.w3.org/2001/XMLSchema#string

P698

11309497

http://www.w3.org/2001/XMLSchema#string

P932

33205

http://www.w3.org/2001/XMLSchema#string